neuroClues®
neuroclues.com
Actively hiring
Information Security
Cybersecurity
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
LeanSquare
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020
Founded
Registers and programsofficial lists and records that name the company
| Legal entity | P3Lab SRL | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
LeanSquare Similar startupsby what they do, their industry and backers
The AI-powered cybersecurity human risk management platform. Adaptive training, autonomous phishing, real-time threat intel, quantified…
Deepwatch operates a managed security platform combining detection engineering with expert analysts. Its service tunes customer telemetry…
Casco maps and attacks your running product with AI agents, preserves reproducible exploit evidence, offers optional human verification…
Saudi-built OT cybersecurity: the FENNEC platform, OT assessments, and a 24/7 managed OT SOC aligned with NCA OTCC and IEC 62443. Book a…
Streamline and fortify security and compliance workflows with AI and automation from Vendict. Expedite security questionnaires and…
Engineer the Behavioral Defenses of your company with CYBERDISE BDE! Discover how our new Version 3.2 bridges the behavioral gap, turning…
News
neuroClues: €10 Million Series A Secured To Scale AI-Powered Neurological Biomarkers Across Europe
neuroClues announced a €10 million Series A funding round to accelerate the rollout of its AI-powered neurological biomarker platform across Europe, bringing its total capital raised to €25 million, including additional non-dilutive funding. The round was
Read more
Report
neuroClues has raised €10M to support Parkinson's diagnosis
neuroClues has raised €10M in a Series A to commercialise its CE-marked eye-tracking device to support early Parkinson's and Alzheimer's diagnosis.
Read more
Report
NeuroClues: the clinical must-have for Neurologists: clinical validation, industrialization, and go-to-market. NeuroClues: the clinical must-have for Neurologist Projet Fiche descriptive HORIZON CORDIS Commission européenne
P3Lab developed NeuroClues, a first-of-a-kind portable, fast and easy to use eye tracking medical device that brings clinically validated eye movement biomarkers for movement disorders (MDs) into the clinical routine of neurologists. NeuroClues will enabl
Read more
Report
NeuroClues: the clinical must-have for Neurologists: clinical validation, industrialization, and go-to-market. NeuroClues: the clinical must-have for Neurologist Projekt Arkusz informacyjny HORIZON CORDIS Komisja Europejska
P3Lab developed NeuroClues, a first-of-a-kind portable, fast and easy to use eye tracking medical device that brings clinically validated eye movement biomarkers for movement disorders (MDs) into the clinical routine of neurologists. NeuroClues will enabl
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.